Tag Archives: David Martin, PhD, MBA

Concordia International (CXR) Gets a Hold Rating from Bloom Burton

Concordia International (TSX: CXR), the Healthcare company, has received a rating update from a Wall Street analyst on September 11. Bloom Burton’s analyst David Martin, PhD, MBA reiterates their Hold rating on the shares. Read also: Here’s Why Arrowhead (ARWR)